Skip to main content
Medicine logoLink to Medicine
. 2020 Sep 25;99(39):e22262. doi: 10.1097/MD.0000000000022262

Effectiveness and safety of massage in the treatment of anxiety and depression in patients with cancer

A protocol for systematic review and meta-analysis

Siyu Qin a, Yuanyi Xiao a, Zhenhai Chi b, Daocheng Zhu b, Pan Cheng a, Ting Yu a, Haiyan Li a, Lin Jiao b,
PMCID: PMC7523760  PMID: 32991424

Abstract

Background:

Anxiety and depression, complications of cancer, are prevalent but often overlooked mental illnesses. Studies have demonstrated that massage therapy is useful in relieving anxiety and depression of cancer survivors. However, the mechanism is still unclear and no systematic review has provided sufficient evidence for the treatment. Therefore, this protocol is carried out to comprehensively evaluate the reliability of cancer patients with anxiety and depression treated by massage.

Methods:

We will systematically search the relevant literature from PubMed, Cochrane Library, EMBASE, Web of Science, Wanfang, Chongqing VIP, CNKI and Chinese Biomedical Literature Database from the establishment of the databases to June 1, 2020. In addition, we will only include randomized controlled trials about massage for cancer survivors with anxiety and depression, regardless of language and publication status. Two experienced researchers will separately screen the literature, collect data, analyze data and synthesize data using RevMan V.5.3 software. The quality of the included trials in the study will be assessed by the Cochrane bias risk assessment tool.

Results:

The protocol for the meta-analysis will systematically evaluate the reliability of massage therapy for cancer patients with anxiety and depression.

Conclusion:

This conclusion will provide an important basis for evaluating whether massage is reliable in treating cancer survivors who feel anxious and depressed.

INPLASY registration number:

INPLASY202060101

Keywords: anxiety, cancer, depression, massage, protocol, systematic review

1. Introduction

Cancer, a concerning public health problem, threatens the health of human beings all over the world. There are 18.1 million new cancer patients and 9.6 million cancer deaths in 2018.[1] Not only the physical health of patients but also their mental health can be significantly affected by a diagnosis of cancer.[2] Anxiety and depression, complications of cancer, are prevalent but often overlooked mental illnesses.[3] Many research have also shown that the most common psychological states with cancer patients are anxiety and depression.[49] Meanwhile, two-thirds of cancer survivors with depression are often associated with significant anxiety in the clinical.[10] Currently, a series of studies have reported that anxiety and depression can produce some negative effects on patients’ quality of life (QOL), health expenditures, continuity of treatment, and cancer survival.[3,11,12] Therefore, it is very important to find more effective treatments alleviating anxiety and depression symptoms of patients who have been diagnosed with cancer.

At present, pharmacotherapy and psychotherapy, the main treatment means for anxiety and depression of cancer survivors, play an important role in improving these distressing emotions.[2,3,12,13] However, antidepressants and anxiolytics may bring a variety of adverse impacts such as headaches, addiction, seizures, suicide, and interactions with anticancer treatments.[1315] Besides, the psychological intervention available to patients is also limited due to the lack of providers and financial resources.[16] So, it is extremely necessary to seek an alternative treatment that is effective, cheaper, and safer. It is reported that Complementary and Alternative Medicine interventions are used by more than half of cancer patients to relieve related symptoms.[17] Nowadays, massage which is 1 of the most widely used complementary and alternative medicine therapies can not only relieve cancer-related symptoms but also bring physical and mental pleasure.[18]

Massage, defined as a method of manipulating body tissue by hand, has certain effects on the vessel, nerves, and muscle system of the body.[19] Compared to pharmacotherapy and psychotherapy, massage has unique advantages because of its non-invasive, low-cost, and safety characteristics.[20] According to a report, in North American medical centers, massage treatment as a supportive treatment is gradually available for cancer survivors to improve comfort level, lessen symptoms and related side effects.[21] Many studies have found that massage can reduce muscle fatigue, improve blood flow, relax mood as well as relieve cancer symptoms such as anxiety, depression, pain, and nausea.[20,2224]Moreover, the result which was published in the Journal of Clinical Oncology (JCO) also demonstrated that massage could relieve anxiety and depression of cancer survivors.[25]

To our knowledge, there is no recent systematic review discussing whether massage therapy is safe and effective in treating anxiety and depression symptoms of patients who have been diagnosed with cancer. Therefore, we perform this protocol to comprehensively assess the effect of massage for cancer patients who feel anxious and depressed.

2. Methods

2.1. Study registration

The registration number of this study is INPLASY202060101. We will strictly perform this protocol by following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses Protocol (PRISMA-P) statement guidelines.[26]

2.2. Inclusion criteria for study selection

2.2.1. Type of studies

Only randomized controlled trials (RCTs) about massage for cancer survivors with anxiety and depression will be included. There are no restrictions on language and publication status. In addition, non-RCTs, experience report, reviews will not be included.

2.2.2. Types of Participants

All cancer patients feeling anxious and depressed will be included. There are no limitations for age, ethnicity, and gender.

2.2.3. Types of interventions

2.2.3.1. Experimental interventions

The experimental group will only include massage therapies, which include reflexology, acupressure, manual lymphatic drainage, tuina, general massage, etc. There is no restriction on the types of massage, treatment sites, treatment time, and the frequency.

2.2.3.2. Control interventions

The interventions of the control group will include any therapies without massage, such as drugs, psychotherapy, routine care, placebo, cupping therapy, acupuncture, etc.

2.2.4. Types of outcome measures

2.2.4.1. Primary outcomes
  • 1.

    The State Anxiety Inventory.

  • 2.

    The Center for Epidemiological Studies Depression scale.

2.2.4.2. Additional outcomes
  • 1.

    The Quality of Life Questionnaire Core 30 from the European Organization for Research on Treatment of Cancer.

  • 2.

    Any adverse events.

2.3. Search methods

RCTs relating to massage management for anxiety and depression of cancer survivors will be retrieved from PubMed, Cochrane Central Register of Controlled Trials, EMBASE, Web of Science, Chinese Biomedical Literature Database, Wanfang Database, Chongqing VIP Database and Chinese National Knowledge Infrastructure from the establishment of the databases to June 1, 2020. In addition, The Clinicaltrials.gov, Chinese Clinical Trial Registry will also be carefully retrieved to obtain unpublished or ongoing trial data. The detailed PubMed searching strategy is listed in Table 1.

Table 1.

Search strategy used in PubMed database.

2.3.

2.4. Data collection and analysis

2.4.1. Selection of studies

All searched literature will be imported into EndNote software (V.X9) for removing duplicate literature. The 2 researchers (SQ and YX) will independently read the title and abstract to exclude irrelevant literature. After preliminary screening, they will carefully read the full text to determine whether the related studies are eventually included in the protocol. Then, a cross-check will be conducted by 2 researchers (SQ and YX). Finally, if there is any disagreement when the 2 researchers perform the above operation, it will be discussed or resolved by the third researcher (LJ). The specific literature screening flow chart will be presented in Figure 1.

Figure 1.

Figure 1

Flow diagram of study selection process.

2.4.2. Data extraction and management

Two researchers (SQ and ZC) will separately extract the following informations by using data extraction forms which have been prepared in advance:

  • (1)

    Research Characteristics: Year of publication, Journal, title, information of the author.

  • (2)

    Participants’ basic information: Gender, age, course of the disease, country, sample size, severity of anxiety, and depression.

  • (3)

    Study methods: Randomization, allocation concealment, blinding, result analysis method.

  • (4)

    Intervention: Operation name, treatment sites, treatment time, course of treatment, and frequency.

  • (5)

    Outcomes measurement: Primary and secondary outcomes.

2.5. Evaluation of bias risk in included studies

Two experienced researchers (SQ and ZC) will separately assess the quality of the trials using the Cochrane bias risk assessment tool.[27] It includes 7 aspects: random sequence generation, allocation concealment, blinding of participants and personnel, blinding of outcome assessment, incomplete outcome data, selective outcome reporting, and other bias. Each item can be classified as high, low, and unclear risk bias levels. When the items related to studies are not clear, we will contact the authors to get the required information. It is necessary to consult the third researcher (LJ) to make a reliable decision if there is any controversy.

2.6. Data synthesis

The following data analysis will be performed using RevMan 5.3 software. When the measured outcomes are dichotomous data, the risk ratio (RR) with 95% confidence interval (CI) will be adopted. When the measured outcomes are continuous data, Weighted Mean Difference (WMD) with 95% CI will be adopted if we use the same measurement instrument. And the Standardized Mean Difference (SMD) with 95% CI will be applied if we use different measurement instruments. χ2 test and I2 test will be utilized to investigate the heterogeneity. When the heterogeneity is considered to be not obvious (P > 0.1 or I2 < 50%), we will choose the fixed-effect model. On the contrary, when the heterogeneity is considered to be obvious (P ≤ 0.1 or I2 ≥ 50%), the random-effect model will be chosen and the subgroup analysis or sensitivity analysis will be conducted to seek potential causes of intergroup heterogeneity. A descriptive analysis is necessary to be carried out if the heterogeneity is too significant.

2.7. Management of missing data

If the data of the included studies are unclear or missing, we will do our best to contact the related authors of the article to acquire complete data. If the above way of obtaining data information is unsuccessful, we will only use current data for the data analysis.

2.8. Subgroup analysis

If significant heterogeneity exists in the included trials, it is necessary to perform a subgroup analysis to reduce heterogeneity between groups based on differences in massage methods, course of the disease, sample size, the severity of anxiety and depression, and so on.

2.9. Sensitivity analysis

If necessary, sensitivity analysis will be performed to evaluate whether the conclusions of the meta-analysis are stable or reliable by excluding trials of low quality.

2.10. Assessment of reporting biases

Funnel plots will be adopted to detect the publication bias if the included trials exceed 10. Egger test will be performed to analyze the potential causes of publishing bias if the asymmetry exists in the funnel plots.

2.11. Quality of evidence

The quality of evidence will be independently evaluated by 2 researchers using the Grading of Recommendations Assessment, Development, and Evaluation (GRADE),[28] and will be assessed into high, moderate, low, and very low levels.

2.12. Ethics and dissemination

In the study, patients’ personal information is not involved, so ethical approval is not necessary. Results from this protocol will be disseminated in a peer-reviewed journal.

3. Discussion

Anxiety and depression, complications of cancer, seriously affect the mental health of cancer patients. Even though drug therapy and psychotherapy are effective in relieving anxiety and depression, these treatments may have some side effects. Massage as a complementary and alternative therapy has been widely used to alleviate anxiety and depression symptoms of patients who have been diagnosed with cancer, due to its non-invasive, safe, and inexpensive features.[20] Studies have shown that massage therapy can be effective in easing mood and reducing cancer-related symptoms, including depression, anxiety pain, fatigue, and so on.[20,24,25] However, its clinical mechanism of action is still unclear and no systematic review has provided sufficient evidence for this treatment. We hope that the results of this study are useful to patients, clinicians, and health policymakers.

However, the study may have the following limitations: First, significant heterogeneity may exist due to different massage methods, different treatment sites, and time. Second, certain language bias may be caused due to the absence of language limitations.

Author contributions

Conceptualization: Siyu Qin, Yuanyi Xiao.

Data curation: Siyu Qin, Zhenhai Chi.

Formal analysis: Siyu Qin, Yuanyi Xiao.

Funding acquisition: Lin Jiao.

Methodology: Siyu Qin, Zhenhai Chi.

Software: Siyu Qin, Yuanyi Xiao.

Supervision: Lin Jiao.

Writing – original draft: Siyu Qin, Yuanyi Xiao.

Writing – review & editing: Lin Jiao.

Footnotes

Abbreviations: CI = confidence interval, RCTs = randomized controlled trials.

How to cite this article: Qin S, Xiao Y, Chi Z, Zhu D, Cheng P, Yu T, Li H, Jiao L. Effectiveness and safety of massage in the treatment of anxiety and depression in patients with cancer: A protocol for systematic review and meta-analysis. Medicine. 2020;99:39(e22262).

SQ and YX contributed equally to this work and should be considered as co-first authors.

The authors have registered this protocol in the INPLASY network (No. INPLASY202060101).

This study was supported by The National Natural Science Foundation of China (Grant number: 81860877, 81660821); Jiangxi Provincial Science and Technology Department Major Project Innovation Fund Project (Grant number: 20181BBG70047).

The authors have no conflicts of interest to disclose.

The datasets generated during and/or analyzed during the current study are publicly available.

References

  • [1].Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 2018;68:394–424. [DOI] [PubMed] [Google Scholar]
  • [2].Zhang MF, Wen YS, Liu WY, et al. Effectiveness of mindfulness-based therapy for reducing anxiety and depression in patients with cancer: a Meta-analysis. Medicine (Baltimore) 2015;94:e0897. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [3].Pitman A, Suleman S, Hyde N, et al. Depression and anxiety in patients with cancer. BMJ 2018;361:k1415. [DOI] [PubMed] [Google Scholar]
  • [4].Donoyama N, Satoh T, Hamano T, et al. Effects of Anma therapy (Japanese massage) on health-related quality of life in gynecologic cancer survivors: a randomized controlled trial. PLoS One 2018;13:e0196638. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [5].Edman JS, Roberts RS, Dusek JA, et al. Characteristics of cancer patients presenting to an integrative medicine practice-based research network. Integr Cancer Ther 2014;13:405–10. [DOI] [PubMed] [Google Scholar]
  • [6].Cassileth BR. Psychiatric benefits of integrative therapies in patients with cancer. Int Rev Psychiatry 2014;26:114–27. [DOI] [PubMed] [Google Scholar]
  • [7].Samuel CA, Faithfull S. Complementary therapy support in cancer survivorship: a survey of complementary and alternative medicine practitioners’ provision and perception of skills. Eur J Cancer Care (Engl) 2014;23:180–8. [DOI] [PubMed] [Google Scholar]
  • [8].Wu HS, Harden JK. Symptom burden and quality of life in survivorship: a review of the literature. Cancer Nurs 2015;38:E29–54. [DOI] [PubMed] [Google Scholar]
  • [9].Roland KB, Rodriguez JL, Patterson JR, et al. A literature review of the social and psychological needs of ovarian cancer survivors. Psychooncology 2013;22:2408–18. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [10].Brintzenhofe-Szoc KM, Levin TT, Li Y, et al. Mixed anxiety/depression symptoms in a large cancer cohort: prevalence by cancer type. Psychosomatics 2009;50:383–91. [DOI] [PubMed] [Google Scholar]
  • [11].Stark DP, House A. Anxiety in cancer patients. Br J Cancer 2000;83:1261–7. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [12].Smith HR. Depression in cancer patients: pathogenesis, implications and treatment (Review). Oncol Lett 2015;9:1509–14. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [13].Fajemiroye JO, da Silva DM, de Oliveira DR, et al. Treatment of anxiety and depression: medicinal plants in retrospect. Fundam Clin Pharmacol 2016;30:198–215. [DOI] [PubMed] [Google Scholar]
  • [14].Yeung KS, Hernandez M, Mao JJ, et al. Herbal medicine for depression and anxiety: a systematic review with assessment of potential psycho-oncologic relevance. Phytother Res 2018;32:865–91. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [15].Desmarais JE, Looper KJ. Interactions between tamoxifen and antidepressants via cytochrome P450 2D6. J Clin Psychiatry 2009;70:1688–97. [DOI] [PubMed] [Google Scholar]
  • [16].Okuyama T, Akechi T, Mackenzie L, et al. Psychotherapy for depression among advanced, incurable cancer patients: a systematic review and meta-analysis. Cancer Treat Rev 2017;56:16–27. [DOI] [PubMed] [Google Scholar]
  • [17].Vapiwala N, Mick R, Hampshire MK, et al. Patient initiation of complementary and alternative medical therapies (CAM) following cancer diagnosis. Cancer J 2006;12:467–74. [DOI] [PubMed] [Google Scholar]
  • [18].Wilson A. Massage with or without aromatherapy for symptom relief in people with cancer. Res Nurs Health 2018;41:593–4. [DOI] [PubMed] [Google Scholar]
  • [19].Fellowes D, Barnes K, Wilkinson S. Aromatherapy and massage for symptom relief in patients with cancer. Cochrane Database Syst Rev 2004;CD002287. [DOI] [PubMed] [Google Scholar]
  • [20].Cassileth BR, Vickers AJ. Massage therapy for symptom control: outcome study at a major cancer center. J Pain Symptom Manage 2004;28:244–9. [DOI] [PubMed] [Google Scholar]
  • [21].Myers CD, Walton T, Small BJ. The value of massage therapy in cancer care. Hematol Oncol Clin North Am 2008;22:649–50. [DOI] [PubMed] [Google Scholar]
  • [22].Durkin JL, Harvey A, Hughson RL, et al. The effects of lumbar massage on muscle fatigue, muscle oxygenation, low back discomfort, and driver performance during prolonged driving. Ergonomics 2006;49:28–44. [DOI] [PubMed] [Google Scholar]
  • [23].Ouchi Y, Kanno T, Okada H, et al. Changes in cerebral blood flow under the prone condition with and without massage. Neurosci Lett 2006;407:131–5. [DOI] [PubMed] [Google Scholar]
  • [24].Ernst E. Massage therapy for cancer palliation and supportive care: a systematic review of randomised clinical trials. Support Care Cancer 2009;17:333–7. [DOI] [PubMed] [Google Scholar]
  • [25].Wilkinson SM, Love SB, Westcombe AM, et al. Effectiveness of aromatherapy massage in the management of anxiety and depression in patients with cancer: a multicenter randomized controlled trial. J Clin Oncol 2007;25:532–9. [DOI] [PubMed] [Google Scholar]
  • [26].Shamseer L, Moher D, Clarke M, et al. Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation. BMJ 2015;350:g7647. [DOI] [PubMed] [Google Scholar]
  • [27].Higgins JP, Altman DG, Gøtzsche PC, et al. The Cochrane Collaboration's tool for assessing risk of bias in randomised trials. BMJ 2011;343:d5928. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [28].Guyatt GH, Oxman AD, Vist GE, et al. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ 2008;336:924–6. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Medicine are provided here courtesy of Wolters Kluwer Health

RESOURCES